Johnson & Johnson Sells Off Ahead of Earnings: Time to Cut Losses or Double Down?

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 43 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 53%

Johnson & Johnson News

Netflix Inc,ABIOMED Inc

Stocks Analysis by Investing.com (Damian Nowiszewski) covering: Johnson & Johnson, Netflix Inc, ABIOMED Inc. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com

Despite bullish markets, Johnson & Johnson's stock price has declined over 4% year-to-date.Investors eagerly anticipate next week's earnings for insights into Johnson & Johnson's performance.

Investor attention is now turning to the upcoming quarterly results, set to be published next Tuesday. These results present an opportunity for Johnson & Johnson stock to reverse the downtrend, provided the number exceeds forecasts.This company specializes in therapies to break down calcification in arteries, reducing the risk of heart attacks.

If the final readings match forecasts, it will mean a decrease from last year's figures, when earnings per share stood at $2.68 and revenues reached $24.746 billion. This negative outlook contributes to the ongoing selling pressure on the stock.The downward trend that started last month continues, with a high probability of dipping below the $150 per share mark. If sellers succeed in this move, the primary scenario is to target last year's lows of around $145 per share.

Netflix Inc ABIOMED Inc

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bitcoin Correction Could Deepen - Bulls Eye $60k Level as Next Key Buy ZoneMarket Analysis by Investing.com (Damian Nowiszewski) covering: BTC/USD, Bitcoin. Read Investing.com (Damian Nowiszewski)'s Market Analysis on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

EUR/USD Eyes 1.07 Support With CPI, ECB on Tap - Is Now the Time to Short?Forex Analysis by Investing.com (Damian Nowiszewski) covering: EUR/USD. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Silver Bulls in Charge With Eyes on $30+ Levels Ahead of CPICommodities Analysis by Investing.com (Damian Nowiszewski) covering: XAG/USD, Silver Futures. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Cocoa Prices Go Nuts, Coffee Might Follow Suit SoonCommodities Analysis by Investing.com (Damian Nowiszewski) covering: US Coffee C Futures, US Cocoa Futures, London Robusta Coffee Futures. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Canadian Dollar to Follow Crude Oil Higher? Watch for Break Above This Key BarrierForex Analysis by Investing.com (Damian Nowiszewski) covering: USD/CAD, US Dollar Index Futures, Crude Oil WTI Futures. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Gold Futures Soar to Historic Highs: Eyes on Inflation, GDP Data for Next MoveCommodities Analysis by Investing.com (Damian Nowiszewski) covering: XAU/USD, XAG/USD, Gold Futures, Silver Futures. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »